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Abstract. A general understanding of interactions between DNA and 
oppositely charged compounds forms the basis for developing novel 
DNA-based materials, including gel particles. The association strength, 
which is altered by varying the chemical structure of the cationic 
cosolute, determines the spatial homogeneity of the gelation process, 
creating DNA reservoir devices and DNA matrix devices that can be 
designed to release either single- (ssDNA) or double-stranded 
(dsDNA) DNA. This paper reviews the preparation of DNA gel 
particles using surfactants, proteins and polysaccharides. Particle 
morphology, swelling/dissolution behaviour, degree of DNA 
entrapment and DNA release responses as a function of the nature of 
the cationic agent used are discussed. Current directions in the 
haemocompatible and cytotoxic characterization of these DNA gel 
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CTAB : cetyltrimethylammonium bromide 
DDAB : didodecyldimethylammonium bromide 
DTAB : dodecyltrimethylammonium bromide 
DTAC : dodecyltrimethylammonium chloride 
DTATf : dodecyltrimethylammonium trifluoromethane sulfonate  
LAM : Nα-lauroyl-arginine-methyl ester hydrochloride 
LS  : lisozyme 
MTT : 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 




 The idea of gene therapy is to transfer genetic material into the cells to 
cure diseases through the expression of certain proteins. Despite significant 
advances in the past couple of decades, gene therapy is still in the clinical  
trial stage, mainly due to the lack of safe and efficient delivery vehicles             
for therapeutic nucleic acids. Deoxyribonucleic acid (DNA) is a negatively 
charged biomacromolecule that is subject to degradation in the bloodstream 
by endogenous nucleases [1]. Moreover, it is too large to cross the cellular 
membranes. A number of strategies are applied to limit DNA degradation, 
such as complexation with cationic species. DNA is a highly charged 
polyelectrolyte and therefore associates strongly with any oppositely charged 
cosolute, including simple ions, polymers, proteins, surfactants, lipids and 
other bioparticles. The interactions of cationic cosolutes with DNA have been 
extensively studied [2]. In general, strong associative phase separation is 
observed. The driving force for this strong association is electrostatic 
interaction between the two components. This is given by entropic increase 
due to the release of the respective counter ions.  
 A general understanding of the interactions between DNA and oppositely 
charged agents, and in particular the phase behaviour, has provided the basis 
for developing novel DNA-based materials, including gels, membranes and gel 
particles [2-4]. We have recently prepared novel DNA gel particles based on 
associative phase separation and interfacial diffusion. The polyelectrolyte of 
interest, DNA, is located in the core of these particles, while the complex 
between oppositely charged polyelectrolytes forms the corresponding shell. By 
mixing solutions of either single- (ssDNA) or double-stranded (dsDNA) DNA 
with solutions of different cationic agents, such as surfactants, proteins and 
polysaccharides, the possibility of forming DNA gel particles, without adding 
any kind of cross-linker or organic solvent, has been confirmed. Table 1 
summarizes the characteristics of the different DNA gel particle systems. The 
association strength, which is altered by varying the chemical structure of the  
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Table 1. Characteristics of the obtained DNA gel particles (see abbreviation list at the 




cationic agent, enables the spatial homogeneity of the gelation process to be 
controlled to produce either a homogeneous DNA matrix or different DNA 
reservoir devices. These can represent a ‘‘bridge’’ for potential applications in 
the controlled encapsulation and release of ssDNA and dsDNA, with clear-cut 
differences in the mechanism. In the following sections, we describe the 
influence of the nature of the cationic agent, i.e. surfactant, protein or 
polysaccharide, on the degree of DNA entrapment, particle morphology, 
swelling/dissolution behaviour, and DNA release responses. 
 
1. Degree of DNA entrapment  
 
 It is of major interest to characterize the degree of DNA entrapment               
on the DNA gel particles. The degree of DNA entrapment can be expressed 
as a function of the loading efficiency (LE) and loading capacity (LC) values. 
LE measures the amount of DNA that is included in the particles with respect 
to the total DNA, during particle formation. LC measures the amount of 
DNA entrapped inside the particles as a function of their weight. 
Characteristics of DNA gel particles, which are formed using surfactants, 
proteins, and polysaccharides as cationic compounds, are summarized in 
Figure 1. All values were measured in triplicate and are given as average and 
standard deviation 
 Except in the case of the double-tail surfactant DDAB, the LE values 
were always higher than 99%, which confirms the effectiveness of DNA 
entrapment in these cationic solutions (Fig. 1a). However, the entrapped





Figure 1. Characterization of the DNA gel particles with respect to DNA loading 
efficiency (a), loading capacity (b) and DNA complexed (c), as a function of the 
cationic compound (surfactants: light grey bars; proteins: dark grey bars; 
polysaccharides: black bars). Representative images of the obtained DNA gel particles 
showing translucent or opaque particles as a consequence of the characteristics of the 
gelation process (d). Adapted from references [5, 8,10].  
 
DNA, as a function of the weight of the particles (LC values), depends on the 
cationic compound used (Fig 1b). The LC values obtained for surfactant-
DNA gel particles depends on the hydrophilic and hydrophobic contributions. 
For the same type of polar head (CTAB and DTAB structures), the 
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hydrophobic contribution did not have a strong influence on the observed LC 
value [6, 7]. Identical LC values were obtained when DNA gel particles were 
prepared with surfactants that only differ in counter ion structure (DTAB, DTAC, 
DTATf) [7]. However, for the same hydrophobic chain length (DTAB, ALA and 
LAM structures), there is a clear effect of the number of charges on the polar 
head. Whereas DTAB and LAM showed one positive charge on the polar head, 
the ALA structure showed two positive charges. Accordingly, higher the number 
of charges, higher the LC values [8]. When the DTAB and DDAB structures are 
compared, we can conclude that higher number of hydrophobic chains on the 
surfactant structure contributes negatively to the LC values [9]. In the case of 
protein-DNA gel particles, the lowest LC value (0.7%) was obtained in particles 
formed with pure LS. Interestingly, highest LC value was obtained for particles 
containing the smallest amount of PS [10]. Molecular weight of the 
polysaccharide structure did not have a clear effect on the LC values [11].    
 An indication of the structural characteristics of these DNA gel particles 
can be deduced from the amount of DNA released, when particles’ breakup is 
mechanically promoted. The percentages of DNA complexed were calculated 
and are summarized in Fig. 1c. Complexed DNA is related to the amounts of 
DNA in the supernatant solutions and the skins derived from the particles, 
after particles were magnetically stirred overnight. In the case of surfactant-
DNA gel particles, the percentages of complexed DNA suggest that, when 
surfactant structures are used with twelve carbon atoms in the hydrophobic 
chain (DTAB, DTAC, DTATf, ALA, LAM), most of the DNA is complexed 
during particle formation [7, 8]. More limited complexation has been 
obtained by increasing, either the alkyl chain length (CTAB), or the number 
of alkyl chains in the molecule (DDAB) [6, 9]. In the case of the protein-
DNA gel particles, the amount of complexed DNA increases progressively in 
the presence of the protein protamine sulphate [10]. The amount of 
complexed DNA in the case of chitosan-DNA gel particles seems to decrease 
when the molecular weight of the polysaccharide is increased [11].   
 This distribution could be correlated with differences in the gelation process 
during particle formation. Homogeneous gelation can lead to homogeneous 
structures (solid particles), whereas a more inhomogeneous gelation process 
forms core-shell structures [13]. In the present study, the model distribution of 
DNA in the particles was supported by visual inspection, since translucent core-
shell particles and opaque condensed particles were found (Fig. 1d).  
 
2. Morphological characterization of the DNA gel particles  
 
 The secondary structure of the DNA molecules in the gels was studied by 
fluorescence microscopy (FM) using acridine orange staining. Acridine 
orange (AO) has been used to label nucleic acids in solution and in intact 
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cells [14-17]. In the case of AO-dsDNA, the fluorescence emission shows a 
maximum around 530 nm, in the green spectra. The association with ssDNA 
shows a maximum around 640 nm, in the red spectra.  
 Based on the observation of green or red emission, AO was used to 
differentiate between native, double-stranded DNA, and denatured, single-
stranded DNA, in the gel particles. Fig. 2a shows fluorescence micrographs 
of individual particles of the surfactant-dsDNA systems.  
 FM studies have revealed that the formation of particles with double-
stranded DNA is carried out with conservation of the secondary structure of the 
DNA. However, in the case of particles formed with denatured DNA, green 
emission is also observed, except in the case of CTAB-ssDNA gel particles. The 
absence of red emission in the particles containing denatured DNA suggests that 
the accessibility of free DNA to the dye is hindered. This observation is 
consistent with our data on DNA distribution (Fig. 2b). The percentage of DNA 
released was less than 0.1%, which confirms the total complexation of the DNA. 
However, when CTAB was used, the amount of ssDNA released reached 20%, 




Figure 2. Fluorescence microscopy micrographs of individual surfactant-DNA gel 
particles in the presence of the DNA selective dye AO (a). Complexed DNA is related to 
the amounts of DNA in the supernatant solutions and the skins derived from the particles, 
after particles were magnetically stirred overnight (b) Adapted from references [6,8,9]. 
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 Scanning electron microscopy imaging was carried out to establish 
possible differences in the morphologies between the different particles.              
Figure 3 shows representative images of CTAB and DTAB surfactants. Clear 
similarities were found in the outer surface morphology between these four 
formulations. However, the surface of the inner structure revealed a different 
structure. Large pores and channel-like structures were found in the inner 
surface of particles formed with CTAB. However, the structure of the particles 
formed with DTAB revealed a more compact structure. The structures obtained 
seem to confirm the degree of complexation between these two surfactants and 
DNA (see Fig. 2b), which increases the shell section of the obtained particles.  
 Similar experiments were carried out on particles formed with the double-
tail surfactant DDAB [9]. In this case, spherical domains formed that were 
visible on the surface of these DDAB-DNA particles (Fig. 4a). The nature of 
these domains was studied using the hydrophobic dye Nile Red (NR) (Fig. 4b) 
[18]. The fluorescence emission of NR, in the presence of DDAB-DNA gel 
particles, was nearly identical to that recorded for DDAB vesicles. This 
indicates that the observed spherical domains on the surface of the DDAB-
DNA gel particles are composed of hydrophobic layers of the surfactant. The 
examination of the DDAB-DNA gel particles with the DNA-selective dye AO 
revealed that the DNA is also included in these domains. Differences in the 




Figure 3. Scanning electron micrographs of individual CTAB–DNA and DTAB-DNA 
gel particles: outer surface (a) and cross-sections showing both the outer and inner 
surfaces (b). Adapted from references [5,9]. 
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Figure 4. Scanning electron micrographs (a) and fluorescence microscopy using Nile 
Red (b) and Acridine orange (c) dyes of individual DDAB-dsDNA and DDAB-
ssDNA gel particles. Adapted from reference [9]. 
 
 In the case of particles formed with native DNA, the observed vesicular 
domains seem to have grown by fusion of several vesicles, adopting a near-
spherical shape. However, the greater thickness of the vesicular domains 
found in the DDAB–ssDNA particles suggests that the reorganization of 
DDAB vesicles in the presence of denatured DNA takes place with the 
subsequent formation of multilamellar complexes. Although these DDAB–
DNA particles were prepared at the same DNA/DDAB ratio, the results 
indicate that differences in local DNA concentration or some kind of 
inaccessibility of one of the components can be significant. FM images at 
higher magnification also support these differences.  
 
3. Swelling/dissolution behaviour and kinetics of DNA 
release  
 
 Gels are considered to have great potential as drug reservoirs. Loaded 
drugs can be released by diffusion from the gels or by the erosion of them. 
When the DNA gel particles are inserted into a certain medium, different 
responses occur: swelling or deswelling, dissolution, and release of DNA. 
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 In the case of surfactant-DNA gel particles, the extension of the swelling 
process depends on both the surfactant and the nucleic acid structures               
(Fig 5a). For the same hydrophilic contribution (CTAB and DTAB), the 
decrease in the number of carbon atoms in the hydrophobic chain contributes 
negatively to the swelling extension. So, when CTAB-DNA gel particles 
were placed in pH 7.6 10 mM Tris HCl buffer, water was taken up from the 
medium and swelling could be observed. The swelling continued during the 
entire time interval studied (1,200 h) [6]. However, DTAB–DNA particles 
showed an initial swelling and then dissolved completely after 48 h. DTAB-
DNA gel particles have the largest relative weight (RW=4–6, depending on 
the secondary structure of the nucleic acid) [7]. 
 Generally, the release pattern resembles that observed in the 
swelling/dissolution profiles (Fig. 6a). Thus, CTAB-DNA particles placed in 
pH 7.6 10 mM Tris HCl buffer showed no initial burst release: in the first             
24 h, only 1.6, 2.0 and 3.3% of DNA was released, respectively. After 1,200 h, 
69 and 40% of DNA was released from the particles containing dsDNA and 
ssDNA, respectively [6]. Nevertheless, DTAB–DNA particles exhibited fast 
release behaviour by a dissolution mechanism. The corresponding half-lives 
of DTAB–dsDNA and DTAB–ssDNA are 4 and 8 h, respectively. After 24 h, 
more than 97% of the bound DNA was released [7]. 
 For the same hydrophobic contribution (ALA and LAM derivatives), the 
swelling/dissolution behaviour can be modulated by modification of the type 
and number of positive charges on the polar head [8]. Particles containing 
ALA exhibited the largest (relative weight ratio, RW 2-2.5) and the longest 
(more than 1,300 h) swelling process. Particles containing LAM swelled 
(RW 1.5-2.0 using the maximum points as estimate) for up to 10 or 200 h, as 
a function of the secondary structure of the polyelectrolyte, and then started 
to shrink. The results suggest that the stability of the gel particles is given 
mainly by the electrostatic interaction between DNA and the oppositely 
charged surfactant. More stable particles were obtained for ALA than for 
LAM, probably due to its double charge. In addition, in the latter case, the 
stability was higher when denatured DNA was used. Thus, LAM-DNA 
particles exhibited faster release than ALA-DNA particles (Fig. 6a). 
Complete release from LAM-dsDNA particles occurred after 400 h; whereas 
complete DNA release from LAM-ssDNA occurred after 800 h. When the 
formulation contained ALA, the DNA release was slower. Complete DNA 
release was only achieved after 1800 h. With respect to the observed 
differences between ssDNA and dsDNA release, the results agree with our 
previous studies on surfactant and protein systems, which showed a stronger 
interaction with ssDNA than with dsDNA [5,6,]. The rate and the final 
cumulative DNA release depend on its secondary structure. This strongly 
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indicates the important role of hydrophobic interaction in DNA when the 
bases are more exposed, as in the case of ssDNA. 
 Furthermore, the increase in the number of alkyl chains (DDAB) 
contributes positively to the stabilization of the particles [9]. DDAB-DNA 
particles absorbed an amount of water that was twice the initial mass (relative 
weight, RW, of 2, using the maximum points as an estimate). These particles 
had returned to the original particle weight by the end of the experiment 
(1,500 h). In the case of DNA gel particles formed using the double-tail 
surfactant DDAB, an initial burst release was observed (Fig 6a). The duration 
of this burst release (24 h) was independent of the secondary structure of the 
nucleic acid used, but not of the amount released. The amount of DNA 
released in the first 24 h was 44% and 15% for DDAB–dsDNA and DDAB–
ssDNA particles, respectively. The presence of this burst suggests that some 
DNA is not encapsulated, or DNA is bound weakly on the surface of the 
particles. From 24 to 600 h, a plateau was observed in the cumulative DNA 
release. After that, particles placed in the buffer solution showed a change in 
release kinetics. A linear cumulative release was observed until the end of the 
experiment (1,500 h). The amount of DNA released from DDAB–dsDNA 
and DDAB–ssDNA was 63 and 34%, respectively. 
 Concerning protein-DNA gel particles, LS-DNA gel particles lost weight 
rapidly and extensively (Fig. 5b) [10]. In the case of PS-DNA particles, the 
largest relative weight ratio was observed (RW>5). For the high LS/PS ratio, 
particles absorbed a water amount of 2-3 times the initial mass (relative 
weight ratio, RW, of 2-3) during the swelling process. With a decrease in the 
LS/PS ratio, more moderate absorption of water was observed (RW=1-2). 
When the particles contained PS, there was a common trend in the swelling 
profiles, in which initial swelling was visible before the particle started to 
dissolve. The initial period in the swollen state, before dissolution takes 
place, was independent of the PS content and lasted approximately 100 h 
(using the maximum of the first peak as an estimate). Then, a short period of 
stabilization was observed after a new, more limited, maximum appeared 
(located around 400 h). Thereafter, the RW value became approximately 
constant, with two exceptions. For PS-DNA particles, RW increased with 
time, while for the LS-PS15 system, nonmonotonic behaviour was observed. 
 LS-DNA particles exhibited fast burst release behaviour by a dissolution 
mechanism (Fig. 6b). After 24 h, 84% of the bound DNA was released. When 
the formulation contained PS, the initial burst release was absent. The 
percentage of DNA released in the dissolution media, after 24 h, varied from 
0.4 to 1.0% for protein mixed systems. The absence of a burst effect suggests 
that minimal amounts of unencapsulated DNA are present on the surface of 
the particles after their formation. For particles containing both proteins, the 
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profiles showed slower DNA release than in the pure systems. The release 
rates remained almost constant in the case of particles formed at a high LS/PS 
ratio (LS-PS15 and LS-PS30). However, with a decrease in the LS/PS ratio, a 
sudden acceleration of the release was observed after ≈       400 h. We can assume 
that complete hydration of the core in our particles could occur after 400 h, 
taking into account the presence of the maximum RW values in the swelling-
dissolution experiments (Fig. 5b). This matrix swelling behaviour could 
determine the change in the rate of DNA release, which became dependent on 
the LS/PS ratio. In addition, the final release percentage was largely 
dependent on the LS/PS ratio. As indicated by the arrow in Figure 5, the 
formulations with the lowest PS content released only a small percentage of 
the DNA present in the particles (<20%), but this percentage increased with 




Figure 5. Time-dependent changes in relative weight RW measurements performed 
on surfactant-DNA (a), protein-DNA (b) and polysaccharide-DNA (c) gel particles 
after exposure to pH 7.6 10 mM Tris HCl buffer solutions. Where Wi stands for the 
initial weight of the particles and Wt for the weight of the particles at time t. Adapted 
from references [10,11]. 
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Figure 6. Time-dependent changes in DNA release measurements performed on 
surfactant-DNA (a), protein-DNA (b) and polysaccharide-DNA (c) gel particles, after 
exposure to pH 7.6 10 mM Tris HCl buffer solutions.  Adapted from references [10,11]. 
 
 The determination of the kinetics of swelling and dissolution behaviour 
demonstrated that chitosan-DNA gel particles lost weight rapidly and 
extensively (Fig. 5c). The molecular weight of chitosan has a significant 
effect on the encapsulation of DNA and on the in vitro release properties. The 
release of DNA from the different particles is illustrated in Fig. 6c. Generally, 
DNA release rates in the initial period were high in all cases. In the first 24 
hours, 57%, 71%, and 74% of DNA were released from the particles containing 
low, medium and high molecular weight chitosan, respectively [11]. 
 
4. Determination of in vitro biocompatibility    
 
 The safety evaluation of new products or ingredients destined for human 
use is crucial prior to exposure. Rapid, sensitive and reliable bioassays are 
required to examine the toxicity of these substances. Established cell lines 
areuseful alternative test systems for this kind of toxicological studies [19]. 
However, they must be chosen with care with regard to their origin [20]. 
Cytotoxicity assays are among the most common in vitro endpoints used to 
predict the potential toxicity of a substance in a cell culture [21]. It is 
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essential to understand the interactions of the DNA-based particles with cells 
in vitro to improve their behaviour in vivo.  
 Nano-sized materials (NMs) have a high potential in technical and 
medical applications provided they are not toxic. Despite the significant 
scientific interest and promising potential, the safety of nanoparticulate 
systems remains a growing concern, considering that biological applications 
of nanoparticles could lead to unpredictable effects. The prediction of toxicity 
is difficult, but cytotoxicity screening, which is routinely used in drug 
screening, gives a good indication of potential adverse effects in cells. These 
screening assays are also used for NMs. As a general rule, nano-sized 
materials show higher reactivity than bulk materials of the same composition. 
Therefore, toxicity data must be interpreted in the context of the 
physicochemical characteristics of the NM [22]. 
 Size, surface charge, and hydrophobicity interact in complex ways and 
have a pronounced influence on biocompatibility. Aggregation of NMs in 
physiological fluids is often observed. Based on the assumption that a 
decrease in cellular vitality reduces physiological function, cellular products 
and cell number, cytotoxicity screening assays that measure enzymatic 
activities or cell products have been carried out. These assays perform 
reliably with chemical compounds but can produce false results by 
interference with NMs. Most examples have been published for the MTT 
assay, which is based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide by cellular dehydrogenases. NMs interfere with 
the assay by light absorbance, reduction of the tetrazolium salt, and binding 
of the formazan salt [23]. Interactions of NMs with assays include 
interference by adsorption of dyes [24], absorbance [25], fluorescence [26], 
binding of proteins [27], dye degradation [28], and dye formation [24] among 
others. The most important conclusion drawn from these studies was that 
more than one cytotoxicity assay should be used to evaluate NMs. 
 No specific cytotoxicity screening assays and no specific cell lines are 
fixed to study the effect of NMs. Therefore, a variety of cell lines are being 
used for cytotoxicity screening. Usually, the concentration that has a half-
maximal effect on the decrease of viability is considered as the toxic 
concentration (TC50), effective concentration (EC50), or inhibitory 
concentration (IC50). 
 Although no prominent variation between species have been reported for 
conventional chemicals, NMs may react differently. An investigation of the 
cytotoxicity of cationic polystyrene nanospheres in five cell lines was 
reported. It was found that despite uptake in all cell lines, the nanospheres 
only affected cytotoxicity in two lines [29]. The different reaction of the cell 
lines may be due to their specific characteristics. Potential parameters that 
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could influence the results of the cytotoxicity screening of NMs include the 
phagocytic capacity of the cells. Other cellular parameters, like doubling 
time, size, embryonic origin etc., could also play their role. Knowledge about 
such potential differences can help in the design of cytotoxicity testing of 
new NMs and in explaining cytotoxicity data that varies between laboratories. 
 One of the most common non-epithelial cell lines used in short- and 
long-term nanotoxicological in vitro studies on: cytotoxicity, 
biocompatibility, or mechanisms of cellular uptake of nanoparticles, are the 
3T3 fibroblasts. These are readily available, undergo contact inhibition, and 
are more closely representative of a physiologic model than cancer cell lines, 
for example [30]. Our group studies have demonstrated that the cytotoxicity 
of cationic nanovesicles differed depending on the cell lines as well as the in 
vitro endpoint that was measured. This shows that the selected cell type and 
assay can affect the final outcome, as indicated by other authors [22, 24]. 
Overall, our findings showed that nanovesicle composition plays a primary 
role in underlying toxicity. The cytotoxic responses of the nanovesicles 
varied especially as a function of the cationic charge position on the 
amphiphile that was included in them. Furthermore, the surfactant with the 
highest hydrophobicity tends to enhance the toxic potential of the 
formulations. All these findings suggest that differential toxicity according to 
vesicle composition could be an important concept when new nanomaterials 
are developed for biomedical applications. In conclusion, the combination of 
all assays used in the present study offers an in-depth and comprehensive 
evaluation of the potentially toxic effects of nanomaterials [31].  
 Another problem involved in the determination of the cytotoxic effect of 
nanomaterials is interference with the medium and possible changes in size, 
when they are incorporated into the cell culture medium. The adequate size 
characterization of nanomaterials is a prerequisite for meaningful outcomes 
of nanotoxicity studies [32]. Indeed, in contrast to synthetically produced 
nanoparticles, nanovesicles are much less homogeneous in size and 
composition. Thus, aggregation of nanovesicles and size distribution will 
affect the outcome of toxicity tests dramatically, as larger particles may settle 
faster in cell culture, and are less available to cells than smaller ones, that 
remain in suspension longer and are thus available for incorporation via 
endocytosis [33]. Obviously, there are numerous methods for the 
characterization of nanomaterials [34], but no single method will permit a 
description of nanovesicle characteristics that can support an improved 
interpretation of the in vitro effect data. In studies of the toxicity of 
nanovesicles, cytotoxicity assays should be performed for the nanovesicles 
and for different components such as the cationic surfactants involved in 
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these particles. Our group has evaluated the cytotoxicity of different cationic 
surfactants [35,36]. 
 Another important feature in the development of nanoparticulate systems 
for parenteral administration is to determine their ability to cause haemolysis 
by interaction with the cell membrane. The potential uses of colloidal self-
assemblies as drug delivery systems make haemolysis evaluation very 
important. To this end, we examined this interaction by using erythrocytes as 
a model biological membrane system, since erythrocytes have been used as a 
suitable model for studying the interaction of amphiphiles with biological 
membranes [7, 37-39] Most in vitro studies of surfactant-induced haemolysis 
evaluate the percentage of haemolysis by spectrophotometry, to detect 
plasma-free haemoglobin derivatives after incubating surfactant solutions 
with blood and then separating undamaged cells by centrifugation. However, 
in the case of particles, the interpretation of the results of these studies is 
complicated, due to the variability of experimental approaches and a lack of 
universally accepted criteria for determining test-result validity. 
 Studies of our group carried out with surfactant-DNA gel particles have 
demonstrated that the amount of DNA that is released and the haemolytic 
response induced by surfactant-DNA gel particles are strongly dependent on 
both the structure of the counter ion in the surfactant and the secondary 
structure of the DNA [7]. One drawback of these surfactant-DNA gel 
particles, in toxicological terms, is the need for a cationic surfactant, which 
may cause some cellular damage. However, our results indicate that the effect 
of the surfactant can be modulated when administered in the DNA system, 
unlike an aqueous solution. This modulation is due to the strong interaction 
between the surfactant and the biopolymer, which leads to very slow release 
of the surfactant from the vehicle.  
 The surfactant-DNA interaction reflects both the release of 
haemoglobin (degree of haemolysis) and the release of DNA into the 
media, as a consequence of the dissolution kinetics of the polyelectrolyte-
surfactant complexes. Under the experimental conditions in which the 
haemolysis studies took place, the amount of dsDNA that is released at the 
end of the experiment (180 min) reaches 100 mg/mL. However, with 
particles prepared with denatured DNA, only 10% of this amount is 
released into the media. These differences are supported by visual 
inspection: surfactant–dsDNA particles are completely dissolved at the end 
of the experiment, whereas surfactant–ssDNA particles are still present 
after 180 min. With respect to the surfactant structure, the haemolysis 
response found in these DNA gel particles can be correlated with 
differences in the apparent degree of counter ion dissociation in these 
surfactants from the corresponding micelles.   
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5. Conclusion 
 
 A general understanding of interactions between DNA and oppositely 
charged agents provides a basis for developing novel DNA gel particles. 
When the DNA gel particles are inserted in a medium, different responses 
occur: swelling or deswelling, dissolution, and DNA release. One drawback 
of the DNA gel particles, in toxicological terms, is the need for a cationic 
compound, which may cause some cell damage. However, our results 
indicate that the effect of the cationic agent can be modulated when 
administered in a DNA gel system, rather than in an aqueous solution. While 
toxicity certainly applies for most classical surfactants, we are engaged in 
work on haemocompatible and cytotoxic assessments of DNA gel particles 
prepared with cationic compounds with much improved intrinsic 
biocompatibility. These include surfactants with the cationic functionality 
based on an amino acid [8], polysaccharides [11] and proteins [10]. There is 
special interest in decreasing the size of these DNA gel particles [40], which 
is a prerequisite for cellular uptake and internalization, and subsequent DNA 
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